Medicare Enrolled
Dr. Mohammed Al-Ameri, MD
Pulmonary Disease · Rochester Hills, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Al-Ameri from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Al-Ameri?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Al-Ameri
Dr. Mohammed Al-Ameri is a pulmonary disease specialist in Rochester Hills, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Al-Ameri performed 4,897 Medicare services across 2,785 unique beneficiaries.
Between the years covered by Open Payments, Dr. Al-Ameri received a total of $10,886 from 45 pharmaceutical and/or device companies across 497 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Al-Ameri is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 4% volume in MI
$10,886 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,897
Medicare services
Top 4% in MI for pulmonary disease
2,785
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~258 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
927 | $64 | $177 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
613 | $38 | $125 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
471 | $39 | $75 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
442 | $31 | $135 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
345 | $33 | $105 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
343 | $41 | $95 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
342 | $28 | $155 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
342 | $41 | $90 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
290 | $64 | $210 |
| Overnight continuous oxygen level test This test measures oxygen levels in the blood continuously overnight using a device attached to the ear or finger. |
255 | $18 | $75 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
243 | $95 | $195 |
| Remote physiological data monitoring, 30 days Collection and interpretation of physical parameters transmitted by the patient or caregiver over a 30-day period, requiring at least 30 minutes of professional time. |
97 | $43 | $175 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
80 | $138 | $325 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
48 | $111 | $255 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
43 | $25 | $200 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
16 | $14 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,886
Total received (2018-2024)
Avg $1,555/year across 7 years
Top 12% in MI for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
497
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,729 (98.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$157 (1.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,136
2023
$2,337
2022
$1,875
2021
$1,393
2020
$962
2019
$1,149
2018
$1,034
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$672
HARMONY BIOSCIENCES LLC
$218
GlaxoSmithKline, LLC.
$213
Insmed, Inc.
$187
GENZYME CORPORATION
$167
Regeneron Healthcare Solutions, Inc.
$156
United Therapeutics Corporation
$149
Mylan Specialty L.P.
$93
Actelion Pharmaceuticals US, Inc.
$66
Boehringer Ingelheim Pharmaceuticals, Inc.
$43
Resmed Corp
$42
Genentech USA, Inc.
$24
Grifols USA, LLC
$24
INOGEN, INC.
$23
Merck Sharp & Dohme LLC
$18
Janssen Pharmaceuticals, Inc
$14
ANI Pharmaceuticals, Inc.
$13
3B Medical, Inc.
$13
Top 3 companies account for 51.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,168
GlaxoSmithKline, LLC.
$1,751
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,094
GENZYME CORPORATION
$664
Actelion Pharmaceuticals US, Inc.
$564
Mylan Specialty L.P.
$514
Regeneron Healthcare Solutions, Inc.
$485
United Therapeutics Corporation
$424
Sunovion Pharmaceuticals Inc.
$301
Grifols USA, LLC
$296
Insmed, Inc.
$278
HARMONY BIOSCIENCES LLC
$218
Axsome Therapeutics, Inc.
$195
Electromed, Inc.
$192
Harmony Biosciences LLC
$190
AbbVie Inc.
$155
Merck Sharp & Dohme Corporation
$127
Novo Nordisk Inc
$103
Mallinckrodt Hospital Products Inc.
$101
Amgen Inc.
$81
Inogen, Inc.
$73
Pulmonx Corporation
$72
Advanced Respiratory, Inc
$69
Genentech USA, Inc.
$65
Takeda Pharmaceuticals U.S.A., Inc.
$62
Circassia Pharmaceuticals Inc
$62
Resmed Corp
$58
JAZZ PHARMACEUTICALS INC.
$58
Teva Pharmaceuticals USA, Inc.
$44
Novartis Pharmaceuticals Corporation
$44
Janssen Pharmaceuticals, Inc
$42
Mallinckrodt Enterprises LLC
$42
Merck Sharp & Dohme LLC
$39
Philips Electronics North America Corporation
$37
Penumbra, Inc.
$31
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$29
Vapotherm Inc
$27
INOGEN, INC.
$23
Covis Pharma GmBH
$19
ADVANCED RESPIRATORY, INC
$18
Azurity Pharmaceuticals, Inc.
$16
Celgene Corporation
$14
Gilead Sciences, Inc.
$14
ANI Pharmaceuticals, Inc.
$13
3B Medical, Inc.
$13
Top 3 companies account for 46.1% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIR 11 · AIRSENSE · AIRSUPRA · ALVESCO · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Abraxane · AirDuo Digihaler · Arikayce · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · CHARTIS CATHETER · DUPIXENT · Esbriet · FARXIGA · FASENRA · GLASSIA · Horizant · INOGEN · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · Indigo System · InogenOne · KEYTRUDA · LONHALA MAGNAIR · LUNA · LifeVest · NUCALA · OFEV · OPSUMIT · ORENITRAM · PROSTATE CANCER - DISEASE · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C · Prolastin-C Liquid · Prolia · QULIPTA · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Saxenda · Sunosi · TAGRISSO · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · UTIBRON NEOHALER · Utibron · WAKIX · Wakix · XARELTO · XOLAIR · XYWAV · Xolair · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
104
Per 100K population
8.2
County median income
$95,296
Nearest hospital
ASCENSION PROVIDENCE ROCHESTER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Al-Ameri is a clinical cardiology specialist, with above-average Medicare volume (top 4% in MI), with low-engagement industry engagement in the top 12% of MI peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Al-Ameri experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Al-Ameri performed 927 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Al-Ameri receive payments from pharmaceutical companies?
Yes. Dr. Al-Ameri received a total of $10,886 from 45 companies across 497 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Al-Ameri's costs compare to other pulmonary diseases in Rochester Hills?
Dr. Al-Ameri's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Al-Ameri) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Rochester Hills
Browse pulmonary diseases in Rochester Hills ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in MI
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in MI
Which MI pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology